Unplanned secondary analysis, 1778 node-negative patients: internal mammary-medial supraclavicular irradiation vs none did not improve 20-year overall survival (69.0% vs 68.4%; HR 0.98). Breast cancer deaths fell (10.0% vs 14.2%), other deaths rose (20.9% vs 17.4%).
Secondary analysisn = 1,778
Kaidar-Person et al. Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancer